Clinical Trial Update: Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating a PD-1 antibody in combination with radiotherapy for recurrent or metastatic adrenocortical carcinoma. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Adrenocortical Carcinoma | Phase 2 | Status: RECRUITING